Modelling Time-to-First Recurrence of Gastric Cancer Patients: A Case Study at Tikur Anbesa Specialized Hospital, Addis Ababa, Ethiopia

Authors

Mesfin Esayas Lelisho
Mizan Tepi University, College of Natural and Computational Science, Department of Statistics, Tepi, Ethiopia.

Article Information

*Corresponding author: Mesfin Esayas Lelisho, Mizan Tepi University, College of Natural and Computational Science, Department of Statistics, Tepi, Ethiopia.

Received date: December 10, 2021
Accepted date: January 10, 2022
Published date: February 16, 2022

Citation:  Mesfin Esayas Lelisho. (2022) “Modelling Time-to-First Recurrence of Gastric Cancer Patients: A Case Study at Tikur Anbesa Specialized Hospital, Addis Ababa, Ethiopia.”, J of Gastroenterology and Hepatology Research, 3(2); DOI: http;//doi.org/01.2022/2.10127
Copyright: © 2022 Mesfin Esayas Lelisho. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly Cited.

Abstract

Background:
Gastric cancer is a malignant tumor of the stomach and it is one of the leading causes of death in the world. The study aimed to model time to first recurrence of gastric cancer patients in Tikur Anbesa specialized hospital.

Methods:
The data for this study was Gastric cancer patients under follow- up at Tikur Anbesa Specialized Hospital, Oncology center, Addis Ababa, from 1 January 2015 through 31 December 2019. We used Weibull, log-logistic and lognormal as baseline hazard functions with the gamma and the inverse Gaussian frailty distributions. Data analysis done using R statistical software.  

Results:
The median recurring time of the patients was about 24.7 months with maximum recurring time of 50.83 months of which about 69.04% were experienced first recurrences of gastric cancer. The clustering effect is significant on modeling time to first recurrence of gastric cancer. According to the result from the log-logistic inverse Gaussian frailty model the Gender of the patients, tumor size, treatment taken, vascular invasion, stage of disease, helicobacter pylori infection and histology type were the significant prognostic factors at 5% level of significance. 

Conclusion and Recommendation:

The log-logistic-inverse Gaussian frailty model is the model that best described time to recurrence of the gastric cancer dataset.  Gender of the patients, tumor size, treatment taken, vascular invasion, stage of disease, helicobacter pylori infection and histology type were the determinant prognostic factors. This calls for actions on improvement of patient’s health status and prevent recurrence based on significant risk factors and special attention should be given for patients with such factors.


Keywords: survival data analysis; parametric shared frailty model; acceleration factor; heterogeneity

Background: 
Gastric cancer is a malignant tumor of the stomach and it can develop in any part of the stomach. It is also called stomach cancer [22]. Gastric cancer is one of the leading causes of death in the world and represents a tremendous burden on patients, families, and societies [25]. Based on Global burden of cancer 2018 data, GC is the 5th most common neoplasm and the 3rd most deadly cancer, with an estimated 783,000 deaths in 2018. Over a million new cases of GC are diagnosed, worldwide, each year [2]. Despite the universal decline in GC incidence and mortality, it is still the second most common cancer worldwide [14].   

In this study, the event of interest was the time to first recurrence of GC after treatment. PH model popularized by Cox is the classical model for this kind of data. However, the correct inference based on Cox's models needs identically and independently distributed samples. Often, subjects may be exposed to different risk levels, even after controlling for known risk factors. This is because the covariates that are relevant to the researcher are often unavailable or even unknown. In current study, shared frailty models explored assuming that patients within the same cluster (region) shares similar risk factors, which would take care of the frailty term at region level. The study aimed to model time to first recurrence of gastric cancer patients in TASH.

This thesis considered parametric frailty models to investigate the relationship between different potential covariates (demographic, clinical and environmental factors) and time to recurrence of GC for clustered survival data with random right censoring. The choice of distribution for the hazard is very important than the choice of frailty distribution [6]. The advantage of parametric method over the semiparametric method shows that having distribution may calculate the quantiles, simplicity and completeness are reasons for the popularity of parametric distributions [13]. Hence, in this study Weibull, log-logistic and lognormal baseline hazard functions used. On the other hand, among frailty distribution we have assumed gamma and inverse Gaussian distributions to fit GC data set. Gamma and inverse Gaussian are the two most common choices of frailty distributions due to their mathematical tractability. For comparison of different models, the AIC criteria used

Methods:

Study setting and design:

A retrospective study was conducted on GC patients under follow- up at Tikur Anbesa Specialized Hospital, Oncology center, Addis Ababa, from 1 January 2015 through 31 December 2019. The total number of patients considered in the study was 409 who were patient from all nine regions and two city administrations of Ethiopia. Regions that contribute single patients were omitted. Therefore, a total of 407 GC patients were considered in this study. For analysis of the data, R statistical software has been used.

Variables in the Study:

The response variable is time to first recurrence of GC from registry time to study ends. The explanatory variables considered in this study were: Age (in years),  Gender of patients, Residence, Marital status, Smoking history, Helicobacter pylori infection, Family history, Obesity status, Tumor location, Stage of GC, Initial Treatment,  Vascular invasion, Tumor size and Histology type. These were categorized as follows:

Age were categorized as (≤49,  50-69 and ≥70), Gender(Male and Female), Residence(Urban,  married, divorced and widowed), Smoking history(No, yes), Vascular invasion(Absent, Present), Obesity (Normal, Underweight, Overweight), Family history(Negative, Positive), Tumor location(Non-gastro intestinal and Gastro intestinal), Stage(I, II, III and IV), Treatment taken (Surgery alone, Chemotherapy, Radiotherapy and Combination of ≥2), Helicobacter pylori infection(Absent and Present), Tumor size(<5cm and ≥5cm) and Histology type(Well-differentiated tumors, Poorly differentiated tumors and Signet ring cell cancer). 

Shared frailty models:

A shared frailty model is a random effects model where the frailties are common (or shared) among groups of individuals or spells and are randomly distributed across groups. They are conditional independence model in which frailty is common to all subjects in a cluster. It is also known as a mixture model because the frailties in each cluster are assumed to be random [8].

Conditional on the random term, called the frailty denoted by wi, the survival times in cluster i (1≤i≤ n) are assumed to be independent and an accelerated failure time frailty model which assumes:

hij(t/Xij,wi)=ho(ϕt)exp(β'Xij+wi)

Where

References

  1. Abdulkarimova, U. (2013). Frailty Models for Modelling Heterogeneity (Doctoral dissertation).
  2. Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians, 68(6), 394-424. 
  3. Cao, L., Selby, L. V., Hu, X., Zhang, Y., Janjigian, Y. Y., Tang, L., … & Strong, V. E. (2016). Risk factors for recurrence in T1‐2N0 gastric cancer in the United States and China. Journal of surgical oncology, 113(7), 745-749.  
  4. Chang-Hyun Shin, Woo-Yong Lee, Seung-Woo Hong, and Yeo-Goo Chang (2016). Characteristics of gastric cancer recurrence five or more years after curative gastrectomy. 48(19), 29-34.  
  5. Corral Cordero, F., Cueva Ayala, P., Yépez Maldonado, J., & Tarupi Montenegro, W. (2018). Trends in cancer incidence and mortality over three decades in Quito-Ecuador. Colombia Médica, 49(1), 35-41.  
  6. Do I. and Lee, Y. (2003). Estimating frailty models via Poisson hierarchical generalized linear models. Journal of Computational and Graphical Statistics. 12: 663-681.
  7. Duchateau, L & Goethals, K., Janssen, P., (2008). Frailty models and copulas: similarities and differences. Springer-Verlag, New York, 35(9), 1071-1079.  
  8. Duchateau, L., Janssen, P., Lindsey, P., Legrand, C., Nguti, R., & Sylvester, R. (2002). The shared frailty model and the power for heterogeneity tests in multicenter trials. Computational Statistics & Data Analysis, 40(3), 603-620.
  9. Hougaard, P. (1995). Frailty models for survival data. Lifetime data analysis, 1(3), 255-273.  
  10. Hougaard, P. (2000). Shared frailty models. In Analysis of multivariate survival data (pp. 215-262). Springer, New York, NY.  
  11. Jin, L. X., Moses, L. E., Squires, M. H., Poultsides, G. A., Votanopoulos, K., Weber, S. M., … & Strasberg, S. M. (2015). Factors Associated with Recurrence and Survival in Lymph Node–negative Gastric Adenocarcinoma. Annals of surgery, 262(6), 999-1005.
  12. Kang, W. M., Meng, Q. B., Yu, J. C., Ma, Z. Q., & Li, Z. T. (2015). Factors associated with early recurrence after curative surgery for gastric cancer. World Journal of Gastroenterology: WJG, 21(19), 5934.
  13. Klein and Moeschberger, (1992). Survival Analysis: Techniques for Censored and Truncated data. Survival analysis for left censored data. In Survival analysis: State of the art (pp. 269-288). Springer, Dordrecht.  
  14. Krejs, G. J. (2018). Gastric cancer incidence: epidemiology and risk factors. Digestive diseases, 28(4-5), 600-603.
  15. Lee, J. H., Kim, H. I., Kim, M. G., Ha, T. K., Jung, M. S.,  & Kwon, S. J. (2016). Recurrence of gastric cancer in patients who are disease-free for more than 5 years after primary resection. Surgery, 159(4), 1090-1098.
  16. Leung, W. K. (2018). Wu M Kakugawa Y, Kim JJ, Yeoh KG, Goh KL Wu KC W u DC Sollano, Kachintorn U Gotoda T Lin JT You WC Ng EK Sung J1. Screening for gastric cancer in Asia: current evidence and practice. Lancet Oncol, 9, 279-287. 
  17. Liu, D., Lu, M., Li, J., Yang, Z., Feng, Q., Zhou, M. … & Shen, L. (2016). The patterns and timing of recurrence after curative resection for gastric cancer in China. World journal of surgical oncology, 14(1), 305.  
  18. Moon, Y. W., Jeung, H. C., Rha, S. Y., Yoo, N. C., Roh, J. K., Noh, S. H.,  & Chung, H. C. (2007). Changing patterns of prognosticators during 15-year follow-up of advanced gastric cancer after radical gastrectomy and adjuvant chemotherapy: a 15-year follow-up study at a single Korean institute. Annals of surgical oncology, 14(10), 2730-2737.  
  19. Orditura, M., Galizia, G., Sforza, V., Gambardella, V., Fabozzi, A., Laterza, M.& Lieto, E. (2019). Treatment of gastric cancer. WJG, 20(7), 1635.  
  20. Palli, D., Bianchi, S., Decarli, A., Cipriani, F., Avellini, C., Cocco, P. I. E. R., … & Fraumeni, J. F. (2018). A case-control study of cancers of the gastric cardia in Italy. British journal of cancer, 65(2), 263-266.  
  21. Paoletti, Xavier, Koji Oba, Tomasz Burzykowski, Stefan Michiels, Yasuo Ohashi, Jean-Pierre Pignon, Philippe Rougier et al. “Benefit of adjuvant chemotherapy for resectable gastric cancer a meta-analysis.” (2019).  
  22. Rugge, M., Fassan, M., & Graham, D. Y. (2015). Epidemiology of gastric cancer. In Gastric Cancer (pp. 23-34). Springer, Cham. 
  23. Shiraishi, N., Inomata, M., Osawa, N., Yasuda, K., Adachi, Y., & Kitano, S. (2014). Early and late recurrence after gastrectomy for gastric carcinoma: Univariate and multivariate analyses. Cancer: Interdisciplinary International Journal of the American Cancer Society, 89(2), 255-261.
  24. Wienke, A. (2011). Frailty models in survival analysis. Chapman and Hall/CRC. 
  25. World Health Organization. (2017). The World Health Organization's fight against cancer: strategies that prevent, cure and care. World Health Organization.  
  26. Wu, B., Wu, D., Wang, M., & Wang, G. (2018). Recurrence in patients following curative resection of early gastric carcinoma. Journal of surgical oncology, 98(6), 411.
  27. Yoshida, S., Kozu, T., Gotoda, T., & Saito, D. (2016). Detection and treatment of early cancer in high-risk populations. Best Practice & Research Clinical Gastroenterology, 20(4), 745-765.